**LEARNING METHOD AND MEDIUM**

This educational activity consists of a supplement and fifteen (15) study questions. The participant should, in order, read the learning objectives contained at the beginning of this supplement, read the supplement, answer all questions in the post test, and complete the Activity Evaluation/Credit Request form. To receive credit for this activity, please follow the instructions provided on the post test and Activity Evaluation/Credit Request form. This educational activity should take a maximum of 3.0 hours to complete.

**CONTENT SOURCE**

This continuing medical education (CME) activity captures content from a series of meetings and web conferences conducted by the Cornea, External Disease, and Refractive Society Dysfunctional Tear Syndrome Panel in 2014 and 2015.

**ACTIVITY DESCRIPTION**

The management of dysfunctional tear syndrome (DTS) has traditionally followed established guidelines based on disease severity. In recent years, however, there have been clinical advances that might allow refinement of the management of DTS based on a differential diagnosis of DTS subtypes. New diagnostic tests and treatments are now available to help inform decisions for DTS subtypes. New diagnostic techniques can be applied to the differential diagnosis of DTS in individual patients. Likewise, new treatment modalities can be incorporated into management plans to improve outcomes in patients with different DTS subtypes. The purpose of this activity is to update clinicians on new developments in diagnosis, treatment for patients with DTS, and the application of newer diagnostic tests and treatments for individual patients with DTS.

**TARGET AUDIENCE**

This activity is intended for ophthalmologists and other eye care professionals.

**LEARNING OBJECTIVES**

*Upon completion of this activity, learners will be better able to*:Outline the potential roles of new diagnostic tests for DTSDiscuss recent developments in treatments for DTSApply available evidence on diagnostic techniques and clinical assessment tools for the differential diagnosis of DTS subtypesDesign management plans for patients using treatment modalities that address the underlying disease mechanisms of DTS subtypes

**ACCREDITATION STATEMENT**

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of **New York Eye and Ear Infirmary of Mount Sinai** and MedEdicus LLC. The **New York Eye and Ear Infirmary of Mount Sinai** is accredited by the ACCME to provide continuing medical education for physicians. 
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**AMA CREDIT DESIGNATION STATEMENT**

The **New York Eye and Ear Infirmary of Mount Sinai** designates this enduring material for a maximum of 3.0 *AMA PRA Category 1 Credits™.* Physicians should claim only the credit commensurate with the extent of their participation in the activity.

**GRANTOR STATEMENT**

This continuing medical education activity is supported through unrestricted educational grants from Alcon; Allergan; Bausch & Lomb Incorporated; Blythe; Oasis; Rapid Pathogen Screening, Inc; Santen Pharmaceutical Co, Ltd; Shire; TearLab Corporation; and TearScience.

**DISCLOSURE POLICY STATEMENT**

It is the policy of **New York Eye and Ear Infirmary of Mount Sinai** that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). **New York Eye and Ear Infirmary of Mount Sinai** has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

**DISCLOSURE ATTESTATION**

The contributing physicians listed at the end of this monograph attested to the following:(1)that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;(2)that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and(3)that all reasonable clinical alternatives will be discussed when making practice recommendations.

Full disclosure of faculty/planners and their commercial relationships, if any, can be found at the end of the manuscript before the references.

**OFF-LABEL DISCUSSION**

This CME activity includes discussion of unlabeled and/or investigative uses of drugs. Please refer to the official prescribing information for each drug discussed in this activity for FDA-approved dosing, indications, and warnings.

**For Digital Editions**

***System Requirements:***

If you are viewing this activity online, please ensure the computer you are using meets the following requirements:**Operating System:** Windows or Macintosh**Media Viewing Requirements:** Flash Player or Adobe Reader**Supported Browsers:** Microsoft Internet Explorer, Firefox, Google Chrome, Safari, and Opera**A good Internet connection**

**New York Eye and Ear Infirmary of Mount Sinai Privacy & Confidentiality Policies**

<http://www.nyee.edu/health-professionals/cme/enduring-activities>

**CME Provider Contact Information:** For questions about this activity, call 212-979-4383.

***TO OBTAIN AMA PRA CATEGORY 1 CREDIT™***

To obtain *AMA PRA Category 1 Credit™* for this activity, read the material in its entirety and consult referenced sources as necessary. Complete the evaluation form along with the post test answer box within this supplement. Remove the Activity Evaluation/Credit Request page from the printed supplement or print the Activity Evaluation/Credit Request page from the Digital Edition. Return via mail to Kim Corbin, Director, ICME, **New York Eye and Ear Infirmary of Mount Sinai**, 485 Madison Avenue, 17th Floor, New York, NY 10003 or fax to (212) 353--5703. Your certificate will be mailed to the address you provide on the Activity Evaluation/Credit Request form. Please allow 3 weeks for Activity Evaluation/Credit Request forms to be processed. There are no fees for participating in and receiving CME credit for this activity.

Alternatively, we offer instant certificate processing and support Green CME. Please take this post test and evaluation online by going to <http://tinyurl.com/DTSCME>. Upon passing, you will receive your certificate immediately. You must score 70% or higher to receive credit for this activity, and may take the test up to two times. Upon registering and successfully completing the post test, your certificate will be made available online and you can print it or file it.

***DISCLAIMER***

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of **New York Eye and Ear Infirmary of Mount Sinai**; MedEdicus LLC; Alcon; Allergan; Bausch & Lomb Incorporated; Blythe; Oasis; Rapid Pathogen Screening, Inc; Santen Pharmaceutical Co, Ltd; Shire; TearLab Corporation; TearScience; or *Current Opinion in Ophthalmology.*
